Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma.
Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Jose A. Karam, University of Texas MD Anderson Cancer Center, Houston, TX; Paulo Bergerot, Federal University of Sao Paulo, São Paulo, Brazil; Neeraj Agarwal, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Sumanta K
SK
Pal
Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Jose A. Karam, University of Texas MD Anderson Cancer Center, Houston, TX; Paulo Bergerot, Federal University of Sao Paulo, São Paulo, Brazil; Neeraj Agarwal, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Jose A
JA
Karam
Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Jose A. Karam, University of Texas MD Anderson Cancer Center, Houston, TX; Paulo Bergerot, Federal University of Sao Paulo, São Paulo, Brazil; Neeraj Agarwal, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Paulo
P
Bergerot
Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Jose A. Karam, University of Texas MD Anderson Cancer Center, Houston, TX; Paulo Bergerot, Federal University of Sao Paulo, São Paulo, Brazil; Neeraj Agarwal, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Neeraj
N
Agarwal
D002292:Carcinoma, Renal Cell; D006801:Humans; D007680:Kidney Neoplasms